Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Journal of Immunological Methods
|
February 17, 2000
Loss of ELISA specificity due to biotinylation of monoclonal antibodies
G Høyer-Hansen, M J Hamers, A N Pedersen, et al.
The Journal of Rheumatology
|
December 1, 1975
The origins and relative distribution of polysaccharidases in rheumatoid and osteoarthritic fluids
R W Stephens, P Ghosh, T K Taylor, et al.
Gynecologic Oncology
|
August 25, 2001
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases
R Riisbro, R W Stephens, N Brünner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer
M N Holten-Andersen, R W Stephens, H J Nielsen, et al.
Clinical Chemistry
|
August 3, 1999
Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients
A N Pedersen, N Brünner, G Høyer-Hansen, et al.
Journal of Immunological Methods
|
April 11, 1997
The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA
A N Pedersen, G Høyer-Hansen, N Brünner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 23, 1999
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
C F Sier, N Sidenius, A Mariani, et al.
The EMBO Journal
|
September 2, 1999
Functional overlap between two classes of matrix-degrading proteases in wound healing
L R Lund, J Romer, T H Bugge, et al.
Breast Cancer Research and Treatment
|
December 1, 2001
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
C Holst-Hansen, J A Low, R W Stephens, et al.
Biochemistry
|
August 25, 1992
Heparin binding to the urokinase kringle domain
R W Stephens, A M Bokman, H T Myöhänen, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Journal of Immunological Methods
|
February 17, 2000
Loss of ELISA specificity due to biotinylation of monoclonal antibodies
G Høyer-Hansen, M J Hamers, A N Pedersen, et al.
The Journal of Rheumatology
|
December 1, 1975
The origins and relative distribution of polysaccharidases in rheumatoid and osteoarthritic fluids
R W Stephens, P Ghosh, T K Taylor, et al.
Gynecologic Oncology
|
August 25, 2001
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases
R Riisbro, R W Stephens, N Brünner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer
M N Holten-Andersen, R W Stephens, H J Nielsen, et al.
Clinical Chemistry
|
August 3, 1999
Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients
A N Pedersen, N Brünner, G Høyer-Hansen, et al.
Journal of Immunological Methods
|
April 11, 1997
The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISA
A N Pedersen, G Høyer-Hansen, N Brünner, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 23, 1999
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
C F Sier, N Sidenius, A Mariani, et al.
The EMBO Journal
|
September 2, 1999
Functional overlap between two classes of matrix-degrading proteases in wound healing
L R Lund, J Romer, T H Bugge, et al.
Breast Cancer Research and Treatment
|
December 1, 2001
Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
C Holst-Hansen, J A Low, R W Stephens, et al.
Biochemistry
|
August 25, 1992
Heparin binding to the urokinase kringle domain
R W Stephens, A M Bokman, H T Myöhänen, et al.
Page
of 10